The digital transformation of healthcare is underway, but it will advance further and faster if key stakeholders work ...
It is brutal and very expensive to bring a new transcatheter valve to market. Boston Scientific invested vast amounts of ...
Here are the top 10 takeaways from the late-breaking studies on cardiovascular technologies presented at the 2021 Americ ...
June 7, 2021 — A couple years ago a study showed a mortality safety signal in patients who underwent peripheral artery ...
June 7, 2021 — Edwards Lifesciences recently announced that clinical results from the company's transcatheter mitral and ...
June 7, 2021 — The COVID-19 pandemic has taken a significant toll on cardiovascular clinicians, many of whom provide ...
June 3, 2020 — GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and ...
A year after COVID-19 turned the world upside down, the American Society of Nuclear Cardiology (ASNC) asked members how ...
Tom Jones, M.D., director, cardiac catheterization laboratories, Seattle Children’s Hospital, explains some of the new ...
May 26, 2021 — Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress for the updated ...
May 19, 2021 — Among patients with both heart failure and atrial fibrillation (AFib), treatment strategies focused on ...
May 19, 2021 — A subgroup of patients who experienced an out-of-hospital cardiac arrest (OHCA) that did not respond to ...
May 18, 2021 — Artificial intelligence (AI) derived heart measurements were able to predict COVID-19 (SARS-CoV-2) mortal ...
May 18, 2021 — The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a ...
May 18, 2021 — Dapagliflozin (Farxiga), a sodium-glucose co-transporter 2 (SGLT2) inhibitor, did not significantly ...